Back
Marinus Pharmaceuticals Stock Price Chart
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
33
MRNS
Marinus Pharmaceuticals
Last Price:
0.30
Seasonality Move:
14.27%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing selling pressure, which indicates risk of future bearish movement.
Marinus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.33 | Sell |
| 20-day SMA: | 0.7 | Sell |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 3.4 | Sell |
| 8-day EMA: | 0.36 | Sell |
| 20-day EMA: | 0.64 | Sell |
| 50-day EMA: | 1.05 | Sell |
| 200-day EMA: | 2.93 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 24.73 | Sell |
| Chaikin Money Flow: | -1713004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.2 - 1.6) | Sell |
| Bollinger Bands (100): | (0.85 - 1.73) | Sell |
Marinus Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 0.30 while MRNS 8-day simple moving average is 0.33, which is a Sell signal.
- The stock price of MRNS is 0.30 while Marinus Pharmaceuticals 20-day SMA is 0.70, which makes it a Sell.
- Marinus Pharmaceuticals 50-day simple moving average is 1.26 while MRNS share price is 0.30, making it a Sell technically.
- MRNS stock price is 0.30 and Marinus Pharmaceuticals 200-day simple moving average is 3.40, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Sell
33
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a Sell
The current Marinus Pharmaceuticals [MRNS] share price is $0.30. The Score for MRNS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
16.65M
Price in USD:
0.30
Share Volume:
1.71M
Marinus Pharmaceuticals 52-Week Range
52-Week High:
11.26
52-Week Low:
0.26
Sell
33
Marinus Pharmaceuticals (MRNS)
is a Sell
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?
The Marinus Pharmaceuticals stock price is 0.30 USD today. -
Will MRNS stock go up or go down?
Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Marinus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 0.30 while MRNS 8-day exponential moving average is 0.36, which is a Sell signal.
- The stock price of MRNS is 0.30 while Marinus Pharmaceuticals 20-day EMA is 0.64, which makes it a Sell.
- Marinus Pharmaceuticals 50-day exponential moving average is 1.05 while MRNS share price is 0.30, making it a Sell technically.
- MRNS stock price is 0.30 and Marinus Pharmaceuticals 200-day simple moving average is 2.93, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
- MRNS Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Marinus Pharmaceuticals is a Sell
- Marinus Pharmaceuticals Relative Strength Index (RSI) is 24.73, which suggest Marinus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Marinus Pharmaceuticals is (0.2 - 1.6), which suggest Marinus Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Marinus Pharmaceuticals is (0.85 - 1.73), which suggest Marinus Pharmaceuticals is a Sell
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.